Senna-Lax - 15127-105-01 - (Sennosides)

Alphabetical Index


Drug Information of Senna-Lax

Product NDC: 15127-105
Proprietary Name: Senna-Lax
Non Proprietary Name: Sennosides
Active Ingredient(s): 8.6    mg/1 & nbsp;   Sennosides
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Senna-Lax

Product NDC: 15127-105
Labeler Name: Stephen L. LaFrance Pharmacy, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part334
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 19950127

Package Information of Senna-Lax

Package NDC: 15127-105-01
Package Description: 1 BOTTLE, PLASTIC in 1 CARTON (15127-105-01) > 100 TABLET in 1 BOTTLE, PLASTIC

NDC Information of Senna-Lax

NDC Code 15127-105-01
Proprietary Name Senna-Lax
Package Description 1 BOTTLE, PLASTIC in 1 CARTON (15127-105-01) > 100 TABLET in 1 BOTTLE, PLASTIC
Product NDC 15127-105
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Sennosides
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19950127
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Stephen L. LaFrance Pharmacy, Inc.
Substance Name SENNOSIDES A AND B
Strength Number 8.6
Strength Unit mg/1
Pharmaceutical Classes

Complete Information of Senna-Lax


General Information